Tissue Culture Shared Resource

Home | Services & Fees | Educational Resources | Publications | Schedule


2003 2004 2005 2006 2007 2008 2009 2010 2011 2012


Adhikari S, Karmahapatra SK, Elias H, Dhopeshwarkar P, Williams RS, Byers S, Uren A, Roy R. Development of a novel assay for human tyrosyl DNA phosphodiesterase 2. Anal Biochem. 2011 Sep 1;416(1):112-6. doi:10.1016/j.ab.2011.05.008. Epub 2011 May 12 21620793 3125436

Adhikari S, Karmahapatra SK, Karve TM, Bandyopadhyay S, Woodrick J, Manthena PV, Glasgow E, Byers S, Saha T, Uren A. Characterization of magnesium requirement of human 5'-tyrosyl DNA phosphodiesterase mediated reaction. BMC Res Notes. 2012 Mar 9;5:134. doi: 10.1186/1756-0500-5-134.22405347 3315744

Al-Otaiby M, Tassi E, Schmidt MO, Chien CD, Baker T, Salas AG, Xu J, Furlong M, Schlegel R, Riegel AT, Wellstein A. Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing. Am J Pathol. 2012 Apr;180(4):1474-84. doi: 10.1016/j.ajpath.201 1.12.032. Epub 2012 Feb 14. 22342158 3349901

Amin KS, Banerjee PP. The cellular functions of RASSF1A and its inactivation in prostate cancer. J Carcinog. 2012;11:3. doi: 10.4103/1477- 3163.93000. Epub 2012 Feb 17. 22438769 3307426

Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Isaacs C, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res. 2012 Feb 20;14(1):R33. 22348646 3496151

Barber-Rotenberg JS, Selvanathan SP, Kong Y, Erkizan HV, Snyder TM, Hong SP, Kobs CL, South NL, Summer S, Monroe PJ, Chruszcz M, Dobrev V, Tosso PN, Scher LJ, Minor W, Brown ML, Metallo SJ, Uren A, Toretsky JA. Single enantiomer of YK-4- 279 demonstrates specificity in targeting the oncogene EWS-FLI1. Oncotarget. 2012 Feb;3(2):172-82. 22383402 3326647

Briggs JW, Ren L, Nguyen R, Chakrabarti K, Cassavaugh J, Rahim S, Bulut G, Zhou M, Veenstra TD, Chen Q, Wei JS, Khan J, Uren A, Khanna C. The ezrin metastatic phenotype is associated with the initiation of protein translation. Neoplasia. 2012 Apr;14(4):297-310. 22577345 3349256

Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 2012 Jan 19;31(3):269- 81. doi: 10.1038/onc.2011.2 45. Epub 2011 Jun 27. 21706056 3513970 22

Cabrera MC, Díaz-Cruz ES, Kallakury BV, Pishvaian MJ, Grubbs CJ, Muccio DD, Furth PA. The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin CDKRb pathway. Cancer Prev Res (Phila). 2012 Jun;5(6):810-21. doi: 10.1158/1940- 6207.CAPR-11- 0532-T. Epub 2012 Apr 16. 22508966 3368087

Catalina-Rodriguez O, Kolukula VK, Tomita Y, Preet A, Palmieri F, Wellstein A, Byers S. Giaccia AJ, Glasgow E, Albanese C, Avantaggiati ML. The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. Oncotarget. 2012 Oct;3(10):1220-35. 23100451 25

Cecchi F, Pajalunga D, Fowler CA, Uren A, Rabe DC, Peruzzi B, Macdonald NJ, Blackman DK, Stahl SJ, Byrd RA, Bottaro DP. Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling. Cancer Cell. 2012 Aug 14;22(2):250- 62. doi: 10.1016/j.ccr.2012.0 6.029. 22897854 3422512 26

Cen L, Carlson BL, Schroeder MA, Ostrem JL, Kitange GJ, Mladek AC, Fink SR, Decker PA, Wu W, Kim JS, Waldman T, Jenkins RB, Sarkaria JN. p16-Cdk4-Rb axis controls sensitivity to a cyclindependent kinase inhibitor PD0332991 in glioblastoma xenograft cells. Neuro Oncol. 2012 Jul;14(7):870-81. doi: 10.1093/neuonc/nos 114. Epub 2012 Jun 18. 22711607 3379801

Chung FL, Wu MY, Basudan A, Dyba M, Nath RG. Regioselective formation of acrolein-derived cyclic 1,N(2)- propanodeoxyguanosine adducts mediated by amino acids, proteins, and cell lysates. Chem Res Toxicol. 2012 Sep 17;25(9):1921-8. doi:10.1021/tx3002252. Epub 2012 Aug 14. 22853434 3535281

Cook KL, Shajahan AN, Warri A, Jin L, Hilakivi-Clarke LA, Clarke R. Glucose-Regulated Protein 78 Controls Cross-talk between Apoptosis and Autophagy to Determine Antiestrogen Responsiveness. Cancer Res. 2012 Jul 1;72(13):3337- 49. 22752300 3576872

Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Isaacs C, , et al. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):645- 57. doi: 10.1158/1055- 9965.EPI-11-0888. Epub 2012 Feb 20. 22351618 3319317

Davis GC, Kong Y, Paige M, Li Z, Merrick EC, Hansen T, Suy S, Wang K, Dakshanamurthy S, Cordova A, McManus OB, Williams BS, Chruszcz M, Minor W, Patel MK, Brown ML. Asymmetric synthesis and evaluation of a hydroxyphenylamide voltagegated sodium channel blocker in human prostate cancer xenografts. Bioorg Med Chem. 2012 Mar 15;20(6):2180-8. Epub 2011 Sep 1. 22364743

Deshpande M, Notari L, Subramanian P, Notario V, Becerra SP. Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity. Int J Oncol. 2012 Jul;41(1):219-27. doi: 10.3892/ijo.2012.14 31. Epub 2012 Apr 10. 22504705 3546833

DiVito KA, Trabosh VA, Chen YS, Chen Y, Albanese C, Javelaud D, Mauviel A, Simbulan Rosenthal CM, Rosenthal DS. Smad7 restricts melanoma invasion by restoring Ncadherin expression and establishing heterotypic cellcell interactions in vivo. Mol Cell Biol. 2011 Jul;31(13):2756-71. Epub 2011 May 2. 20738806 2975252

Duong HQ, Hwang JS, Kim HJ, Kang HJ, Seong YS, Bae I. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells. Int J Oncol. 2012 Sep;41(3):855-61. doi: 10.3892/ijo.2012.15 16. Epub 2012 Jun 12. 22710732 3508685

Duong HQ, Hwang JS, Kim HJ, Seong YS, Bae I. BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells. Int J Oncol. 2012 Dec;41(6):2227-36. doi: 10.3892/ijo.2012.16 72. Epub 2012 Oct 17. 23076030

Duong HQ, Kim HJ, Kang HJ, Seong YS, Bae I. ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine. Oncol Rep. 2012 Jan;27(1):182-8. doi: 10.3892/or.2011.150 3. Epub 2011 Oct 12. 21993922 3577930

Fan P, McDaniel RE, Kim HR, Clagett D, Haddad B, Craig Jordan V. Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines. Eur J Cancer. 2012 Dec;48(18):3488-98. doi: 10.1016/j.ejca.2012. 04.020. Epub 2012 Jun 2. 22658320 3518839

Gleason MK, Verneris MR, Todhunter DA, Zhang B, McCullar V, Zhou SX, Panoskaltsis-Mortari A, Weiner LM, Vallera DA, Miller JS. Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production.¬ Mol Cancer Ther. 2012 Dec;11(12):2674-84. doi: 10.1158/1535 7163.MCT-12-0692. Epub 2012 Oct 17. 23075808 3519950

He HH, Meyer CA, Chen MW, Jordan VC, Brown M, Liu XS. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res. 2012 Jun;22(6):1015-25. Epub 2012 Apr 16. 22508765 3371710

Hong YB, Kim JS, Yi YW, Seong YS, Bae I. Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer. Pancreas. 2012 Apr;41(3):496-8. No abstract available. 22415672 3304537

Hou L, Chen M, Ng J, Hurley CK. Conserved KIR allele-level haplotypes are altered by microvariation in individuals with European ancestry.[Natural Killer cell reactivity] Genes Immun. 2012 Jan;13(1):47-58. doi: 10.1038/gene.2011.52. Epub 2011 Jul 28. 21796155 3536055

Hou L, Chen M, Steiner N, Kariyawasam K, Ng J, Hurley CK. Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing.[Tool for donor selection for Natural Killer cell reactivity] Methods Mol Biol. 2012;882:431-68. doi: 10.1007/978-1-61779-842-9_25. 22665249 3478768

Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, McGuffog L, Healy S, Sinilnikova OM, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H; OCGN, Isaacs C, et al. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer. 2012 Jun 5;106(12):2016- 24. doi: 10.1038/bjc.2012.16 0. Epub 2012 May 15. 22669161 3388557

Kang HJ, Hong YB, Kim HJ, Wang A, Bae I. Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cells. Toxicol Lett. 2012 Mar 7;209(2):154-60. Epub 2011 Dec 13. 22192953 3508677

Kang HJ, Yi YW, Kim HJ, Hong YB, Seong YS, Bae I. BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive elementlike site. Cell Death Dis. 2012 Jun 28;3:e336. doi: 10.1038/cddis.2012. 78. 22739988 3388245

Karve TM, Preet A, Sneed R, Salamanca C, Li X, Xu J, Kumar D, Rosen EM, Saha T. BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells. PLoS One. 2012;7(6):e37697. doi: 10.1371/journal.pon e.0037697. Epub
2012 Jun 1. 22685544 3365892

Karve TM, Rosen EM. B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells. J Biol Chem. 2012 Sep 7;287(37):31503-14. doi: 10.1074/jbc.M112.3 67433. Epub 2012 Apr 5. 22493435 3438983

Kim YJ, Hong YB, Cho CH, Seong YS, Bae I. Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancer. Pancreas. 2012 Jul;41(5):804-5. doi: 10.1097/MPA.0b013 e31823f3fcb. No abstract available. 22695089 3375494

Kim YJ, Hwang JS, Hong YB, Bae I, Seong YS. Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabine. Anticancer Res. 2012 Mar;32(3):799-806. 22399597 3508670

Kirilyuk A, Shimoji M, Catania J, Sahu G, Pattabiraman N, Giordano A, Albanese C, Mocchetti I, Toretsky JA, Uversky VN, Avantaggiati ML. An intrinsically disordered region of the acetyltransferase p300 with similarity to prion-like domains plays a role in aggregation. PLoS One. 2012;7(11):e48243. doi: 10.1371/journal.pon e.0048243. Epub 2012 Nov 1. 23133622 3486812

Korch C, Spillman MA, Jackson TA, Jacobsen BM, Murphy SK, Lessey BA, Jordan VC, Bradford AP. DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecol Oncol. 2012 Oct;127(1):241-8. doi: 10.1016/j.ygyno.201 2.06.017. Epub 2012 Jun 16. 22710073 3432677

Lee JS, Lee HJ, Moon BH, Song SH, Lee MO, Shim SH, Kim HS, Lee MC, Kwon JT, Fornace AJ Jr, Kim SU, Cha HJ. Generation of cancerous neural stem cells forming glial tumor by oncogenic stimulation. Stem Cell Rev. 2012 Jun;8(2):532-45. doi: 10.1007/s12015-011-9280-4¬ 21755312

Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, Timofeeva OA, Nealon C, Dakic A, Simic V, Haddad BR, Rhim JS, Dritschilo A, Riegel A, McBride A, Schlegel R. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol. 2012 Feb;180(2):599-607. Epub 2011 Dec 18. 22189618 3349876

Nyfeler B, Chen Y, Li X, Pinzon-Ortiz M, Wang Z, Reddy A, Pradhan E, Das R, Lehár J, Schlegel R, Finan PM, Cao ZA, Murphy LO, Huang A. RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signaling and Tumor Growth. PLoS One. 2012;7(11):e48548. doi: 10.1371/journal.pon e.0048548. Epub 2012 Nov 14. 23155392 3498278

Pan J, Awoyemi B, Xuan Z, Vohra P, Wang HT, Dyba M, Greenspan E, Fu Y, Creswell K, Zhang L, Berry D, Tang MS, Chung FL. Detection of acrolein-derived cyclic DNA adducts in human cells by monoclonal antibodies. Chem Res Toxicol. 2012 Dec 17;25(12):2788-95. doi: 10.1021/tx3004104. Epub 2012 Nov 13. 23126278 3561715

Patacsil D, Tran AT, Cho YS, Suy S, Saenz F, Malyukova I, Ressom H, Collins SP, Clarke R, Kumar D. Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cells. J Nutr Biochem. 2012 Jan;23(1):93-100. Epub 2011 Mar 22. 21429729 3123668

Patacsil, D., Osayi, S., Tran, A.T., Saenz, F., Yimer, L., Shajahan, A.N., Gokhale, P.G., Verma, M., Clarke, R., Chauhan, S.C. & Kumar, D. Vitamin E succinate inhibits survivin and induces
apoptosis in pancreatic cancer cells. Genes Nutr. 2012 Jan;7(1):83-9. doi: 10.1007/s12263- 011 0242-x. Epub 2011 Aug 13. 21842182 3250523

Patacsil, D., Tran, A.T., Cho, Y.S., Suy, S., Saenz, F., Malyukova, I., Ressom, H. Collins, S.P., Clarke, R. & Kumar, D. Gamma-Tocotrienol induced apoptosis is associated with the unfolded protein response in human breast cancer cells. Restoration of DNA-binding and growth suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway. J Nutr Biochem. 2012 Jan;23(1):93- 100. doi: 10.1016/j.jnutbio.20 10.11.012. Epub 2011 Mar 22. 21429729 3123668

Pollock CB, Koltai H, Kapulnik Y, Prandi C, Yarden RI. Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem like enriched mammosphere cells. Breast Cancer Res Treat. 2012 Aug;134(3):1041-55. doi: 10.1007/s10549- 012-1992-x. Epub 2012 Mar 29. 22476848

Pompach P, Chandler KB, Lan R, Edwards N, Goldman R. Semi-automated identification of N Glycopeptides by hydrophilic interaction chromatography, nanoreverse-phase LC-MS/MS, and glycan database search. J Proteome Res. 2012 Mar 2;11(3):1728-40. Epub 2012 Feb 6. 22239659 3292689

Rosenfield SM, Bowden ET, Cohen-Missner S, Gibby KA, Ory V, Henke RT, Riegel AT, Wellstein A. Pleiotrophin (PTN) expression and function and in the mouse mammary gland and mammary epithelial cells. PLoS One. 2012;7(10):e47876. doi: 10.1371/journal.pon e.0047876. Epub 2012 Oct 15. 23077670 3471873

Sahab Z, Sudarshan SR, Liu X, Zhang Y, Kirilyuk A, Kamonjoh CM, Simic V, Dai Y, Byers SW, Doorbar J, Suprynowicz FA, Schlegel R. Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry. J Virol. 2012 Sep;86(17):9465-73. doi: 10.1128/JVI.01032-12. Epub 2012 Jun 27. 22740411 3416135

Sang QX, Man YG, Sung YM, Khamis ZI, Zhang L, Lee MH, Byers SW, Sahab ZJ. Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis. Clin Exp Metastasis. 2012 Feb;29(2):143- 53. doi: 10.1007/s10585- 011-9437 1. Epub 2011 Nov 25.
22116632 3449303

Schlottmann S, Erkizan HV, Barber- Rotenberg JS, Knights C, Cheema A, Uren A, Avantaggiati ML, Toretsky JA. Acetylation Increases EWSFLI1 DNA Binding and Transcriptional Activity. Front Oncol. 2012;2:107. doi: 10.3389/fonc.2012.0 0107. Epub 2012 Sep 7. 22973553 3435532

Shajahan AN, Dobbin ZC, Hickman FE, Dakshanamurthy S, Clarke R. Tyrosine-phosphorylated caveolin-1 (Tyr-14) increases sensitivity to paclitaxel by inhibiting BCL2 and BCLxL proteins via c Jun N-terminal kinase (JNK). J Biol Chem. 2012 May 18;287(21):17682- 92. doi: 10.1074/jbc.M111.3 04022. Epub 2012 Mar 20. 22433870 3366801

Sikora MJ, Strumba V, Lippman ME, Johnson MD, Rae JM. Mechanisms of estrogenindependent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation. Breast Cancer Res Treat. 2012 Aug;134(3):1027-39. Epub 2012 Mar 29. 22456984

Subramanian P, Deshpande M, Locatelli-Hoops S, Moghaddam- Taaheri S, Gutierrez D, Fitzgerald DP, Guerrier S, Rapp M, Notario V, Becerra SP. Identification of pigment epithelium derived factor protein forms with distinct activities on tumor cell lines. J Biomed Biotechnol. 2012;2012:425907. doi: 10.1155/2012/42590 7. Epub 2012 Jun 4. 22701303 3373277

Suprynowicz FA, Upadhyay G, Krawczyk E, Kramer SC, Hebert JD, Liu X, Yuan H, Cheluvaraju C, Clapp PW, Boucher RC Jr, Kamonjoh CM, Randell SH, Schlegel R. Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20035-40. doi: 10.1073/pnas.12132 41109. Epub 2012 Nov 19. 23169653 3523865

Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG, Zhang X, Korostyshevskiy VR, Cheema A, Zhang L, Dakshanamurthy S, Brown ML, Dritschilo A. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem. 2012 Apr 20;287(17):14192- 200. Epub 2012 Feb 29. 22378781 3340179

Ullmann R, Chien CD, Avantaggiati ML, Muller S. An acetylation switch regulates SUMO dependent protein interaction networks. Mol Cell. 2012 Jun 29;46(6):759-70. doi: 10.1016/j.molcel.201 2.04.006. Epub 2012 May 10. 22578841

Vartanian S, Bentley C, Brauer MJ, Li L, Shirasawa S, Sasazuki T, Kim JS, Haverty P, Stawiski E, Modrusan Z, Waldman T, Stokoe D. Identification of mutant KRasdependent phenotypes using a panel of isogenic cell lines. J Biol Chem. 2012 Nov 27. [Epub ahead of print] 23188824 3554910

Wang HT, Weng MW, Chen WC, Yobin M, Pan J, Chung FL, Wu XR, Rom W, Tang MS. Effect of CpG methylation at different sequence context on acrolein- and BPDE-DNA binding and mutagenesis. Carcinogenesis. 2012 Nov 1. [Epub ahead of print] 23042304 3534198

Wang LL, Meng QH, Jiao Y, Xu JY, Ge CM, Zhou JY, Rosen EM, Wang HC, Fan SJ. High mobility group boxes mediate cell proliferation and radiosensitivity via retinoblastoma interactiondependent and ‚Äďindependent mechanisms. Cancer Biother Radiopharm. 2012 Jun;27(5):329-35. doi: 10.1089/cbr.2012.11 99. Epub 2012 Jun 1. 22655796 3375072

Xiao X, Meng Q, Xu J, Jiao Y, Rosen EM, Fan S. EGFR-dependent Impact of Indol-3-Carbinol on Radiosensitivity of Lung Cancer Cells. Zhongguo Fei Ai Za Zhi. 2012 Jul 20;15(7):391-8. Chinese. 22814257

Xu H, Xu Z, Tseng IC, Chou FP, Chen YW, Wang JK, Johnson MD, Kataoka H, Lin CY. Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1. Am J Physiol Cell Physiol. 2012 Jan;302(2):C453-62. Epub 2011 Oct 26. 22031598 3328841

Xu JY, Meng QH, Chong Y, Jiao Y, Zhao L, Rosen EM, Fan S. Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis. Oncol Rep. 2012 Dec;28(6):2264 70. doi: 10.3892/or.2012.202 4. Epub 2012 Sep 11. 22965493

Yarden RI, Metsuyanim S, Pickholtz I, Shabbeer S, Tellio H, Papa MZ. BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest. Int J Biochem Cell Biol. 2012 Jun 26;44(11):1761- 1769. [Epub ahead of print] 22743332

Yenugonda VM, Kong Y, Deb TB, Yang Y, Riggins RB, Brown ML. Trans-resveratrol boronic acid exhibits enhanced antiproliferative activity on estrogen-dependent MCF-7 breast cancer cells. Cancer Biol Ther. 2012 Aug 1;13(10):925-34. Epub 2012 Aug 1. 22785207

Yi YW, Kang HJ, Kim HJ, Hwang JS, Wang A, Bae I. Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells. Mol Carcinog. 2012
Apr 4. doi: 10.1002/mc.21905. [Epub ahead of print] 22488590

Yuan H, , Yin Y, Lu J, Glazer RI. Drug-targeted inhibition of peroxisome proliferatoractivated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy. Oncotarget. 2012;3(3):345-56. 22538444 3359890

Yuan H, Myers S, Wang J, Zhou D, Woo JA, Kallakury B, Ju A, Bazylewicz M, Carter YM, Albanese C, Grant N, Shad A, Dritschilo A, Liu X, Schlegel R. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med. 2012 Sep 27;367(13):1220-7. 23013073

Yuan H, Upadhyay G, Lu J, Kopelovich L, Glazer RI. The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature. Cancer Prev Res (Phila). 2012 May;5(5):754-64. Epub 2012 Mar 16. 22427346 3437618

Yuan H, Upadhyay G, Yin Y, Kopelovich L, Glazer RI. Stem cell antigen-1 deficiency enhances the chemopreventive effect of peroxisome proliferatoractivated receptorÎ3 activation. Cancer Prev Res (Phila). 2012 Jan;5(1):51-60. Epub 2011 Sep 28. 21955520 3252486

Zhang JX, Li DQ, He AR, Motwani M, Vasiliou V, Eswaran J, Mishra L, Kumar R. Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases. Hepatology. 2012 Jun;55(6):1840-51. doi: 10.1002/hep.25566. 22223166 3470855